跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lepixa - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lepixa
Approved
STANDARD
Lepixa
Aspiro Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
74233773049d5cad
Company
Aspiro Pharma Limited
Type
Standard
Approval Details
Approval Id
74233773049d5cad
Drug Approval Philippines Name
Lepixa
Product Name
Lepixa
Registration Number
DRP-9232-03
Brand Name
Lepixa
Generic Name
Levetiracetam
Dosage Form
Solution for Injection (IV)
Dosage Strength
100 mg/mL (500 mg/5mL)
Manufacturer
Aspiro Pharma Limited
Importer
Camber Pharmaceuticals, Inc.
Distributor
Emcure Pharma Philippines Inc.
Company Detail Path
/organization/aspiro-pharma-limited
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
29 March 2022
Expiry Date
09 November 2025
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
74233773049d5cad
Type
Standard
Back to Philippines FDA Approvals